Connecting MoA to Physiologic Actions

Share

Program Content

Activities

  • Connecting MoA to Physiology
    Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2023

    Expires: November 14, 2024

  • Success With New T2D Medications
    Strategies for Clinical Success With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Coagonists
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 07, 2023

    Expires: November 06, 2024

  • Connecting MoA to Physiology
    Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2023

  • MoAs: SGLT2i, GLP-1 RAs, and GIP/GLP-1 RAs
    Mechanisms of Action: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Receptor Coagonists
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 07, 2023

  • Incretin Commentary
    Addressing the Buzz Around Incretin-Based Therapies With Patients
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 21, 2024

    Expires: February 20, 2025

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner